Smith & Nephew plc (SNN) stock fundamentals

Read this company snapshot

Company overview

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Daily valuation snapshot

Read SNN's valuation metrics

1. Company size

   Smith & Nephew plc's recorded market capitalization is $11,954,612,388.9. It measures the market value of the company's equity, rather than its revenue or cash balance.

2. Price relative to earnings

   SNN's recorded P/E is 19.13: about $19.13 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.

3. Price relative to book equity

   SNN's recorded price-to-book ratio is 2.26. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.

Research Smith & Nephew plc with Aurora

Use the snapshot above to ask a specific question about SNN. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow SNN's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.